Clinical Trial Update: Pharmacokinetic Study of Adoport® (Tacrolimus) in Patients With de Novo Kidney Transplantation [Phase 4]

View source ↗

Summary

Phase 4 pharmacokinetic study of tacrolimus (Adoport) in de novo kidney transplant recipients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Adoport (Tacrolimus)

Snippet

Sponsor: University Hospital, Limoges | Conditions: Transplantation, Kidney | Phase 4 | Status: COMPLETED